Amedisys Reports Fourth Quarter and Year End 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amedisys Reports Fourth Quarter and Year End 2020 Financial Results

Amedisys (AMED) Tops Q4 EPS by 2c

February 24, 2021 4:07 PM EST

Amedisys (NASDAQ: AMED) reported Q4 EPS of $1.49, $0.02 better than the analyst estimate of $1.47. Revenue for the quarter came in at $550.71 million versus the consensus estimate of $553.37 million.

GUIDANCE:

Amedisys sees FY2021 EPS of $6.25-$6.47, versus the consensus of $6.31.... More